Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience

Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience

Background: Despite major treatment advances, multiple myeloma remains incurable. The outcome of patients who are refractory to immunomodulatory agents, proteasome inhibitors, and anti-CD38 monoclonal antibodies is poor, and improved treatment strategies for this difficult-to-treat patient populatio...

Full description

Bibliographic Details
Main Authors: Irene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Michaela Binder, Dagmar Wipplinger, Olga Stiefel, Emine Kaynak, Robert Milanov, Christoph Aichinger, Stefanie Nocker, Thomas Bauer, Stefanie Kreissl, Michael Girschikofsky, Andreas Petzer, Ansgar Weltermann, Johannes Clausen
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
multiple myeloma
allogeneic stem cell transplantation
graft-versus-myeloma effect
plasma cell leukemia
haploidentical
bispecific antibody
Online Access:https://www.mdpi.com/2072-6694/15/24/5738

Internet

https://www.mdpi.com/2072-6694/15/24/5738

Similar Items